Ring chromosome 18 abnormality in acute myelogenous leukemia: the clinical dilemma
Reads0
Chats0
TLDR
A case of a ring chromosome 18 abnormality in a patient with newly diagnosed AML with monocytic differentiation, treated as high risk with stem cell transplantation, who developed post transplant lymphoproliferative disorder and died of multi-organ failure.Abstract:
The ring chromosome is a circular, structural abnormality composed of either multiple chromosomes or a single chromosome with loss of genetic material at one or both ends. This chromosomal rearrangement is often unstable with frequent recombinations and may be accompanied by either loss or amplification of genetic material[1]. Considering that ring chromosomes are rare in acute myelogenous leukemia (AML), it is difficult to risk stratify patient prognosis, particularly when the ring chromosome occurs as the sole abnormality. Here we report a case of a ring chromosome 18 abnormality in a patient with newly diagnosed AML with monocytic differentiation. Cytogenetic analysis demonstrated 46, XY, r(18)(p11q21) karyotype in 19 of 34 evaluated metaphase cells. The patient received induction chemotherapy and subsequent allogeneic cord blood transplant from a sex-matched donor, and remained in hematologic and cytogenetic remission for 120 days post transplant. Soon after, he developed post transplant lymphoproliferative disorder and died of multi-organ failure. Although r(18) chromosomal abnormalities were not classified in the recent updated evidence-and expert opinion-based recommendations for the diagnosis and management of AML (likely due to the small number of reported cases), the patient was treated as high risk with stem cell transplantation. This was based on the unstable nature of the ring chromosome and the poor outcomes described in the literature of patients with sole ring 18 abnormalities.read more
Citations
More filters
Journal ArticleDOI
"Perfect" designer chromosome v and behavior of a ring derivative
Ze-Xiong Xie,Bing-Zhi Li,Leslie A. Mitchell,Yi Wu,Xin Qi,Zhu Jin,Bin Jia,Xia Wang,Bo Xuan Zeng,Hui Min Liu,Xiao Le Wu,Qi Feng,Wen Zheng Zhang,Wei Liu,Ming Zhu Ding,Xia Li,Guang Rong Zhao,Jian Jun Qiao,Jing Sheng Cheng,Meng Zhao,Zheng Kuang,Xuya Wang,J. Andrew Martin,Giovanni Stracquadanio,Giovanni Stracquadanio,Kun Yang,Xue Bai,Juan Zhao,Meng Long Hu,Qiu Hui Lin,Wen Qian Zhang,Ming Hua Shen,Si Chen,Wan Su,En Xu Wang,Rui Guo,Fang Zhai,Xue Jiao Guo,Hao Xing Du,Jia Qing Zhu,Tian Qing Song,Jun Jun Dai,Fei Fei Li,Guo Zhen Jiang,Shi Lei Han,Shi Yang Liu,Zhi Chao Yu,Xiao Na Yang,Ken Chen,Cheng Hu,Da Shuai Li,Nan Jia,Yue Liu,Lin Ting Wang,Su Wang,Xiao Tong Wei,Mei Qing Fu,Lan Meng Qu,Si Yu Xin,Ting Liu,Kai Ren Tian,Xue Nan Li,Jin Hua Zhang,Li Xiang Song,Jin Gui Liu,Jia Fei Lv,Hang Xu,Ran Tao,Yan Wang,Ting Ting Zhang,Ye Xuan Deng,Yi Ran Wang,Ting Li,Guang Xin Ye,Xiao Ran Xu,Zheng Bao Xia,Wei Zhang,Shi Lan Yang,Yi Lin Liu,Wen Qi Ding,Zhen Ning Liu,Jun Qi Zhu,Ning Zhi Liu,Roy Walker,Yisha Luo,Yun Wang,Yue Shen,Huanming Yang,Yizhi Cai,Ping Sheng Ma,Chun-Ting Zhang,Joel S. Bader,Jef D. Boeke,Ying-Jin Yuan +93 more
TL;DR: The perfect designer-matched synthetic chromosome V provides strategies to edit sequence variants and correct unpredictable events, such as off-target integration of extra copies of synthetic DNA elsewhere in the genome.
Journal ArticleDOI
Synthetic Genomics: From DNA Synthesis to Genome Design
Lianrong Wang,Lianrong Wang,Susu Jiang,Susu Jiang,Chao Chen,Chao Chen,Wei He,Xiaolin Wu,Xiaolin Wu,Fei Wang,Tong Tong,Tong Tong,Xuan Zou,Xuan Zou,Zhiqiang Li,Jie Luo,Zixin Deng,Shi Chen,Shi Chen +18 more
TL;DR: Using bottom-up assembly and applying genome-wide alterations will improve the understanding of genome structure and function and provide a platform for systematic studies of eukaryotic chromosomes.
Journal ArticleDOI
Gain of 11q by an additional ring chromosome 11 and trisomy 18 in CD5-positive intravascular large B-cell lymphoma.
Katsuya Yamamoto,Kimikazu Yakushijin,Atsuo Okamura,Yoshitake Hayashi,Hiroshi Matsuoka,Hironobu Minami +5 more
TL;DR: The results indicate that the gain of 11q as well as trisomy 18 may be among the recurrent chromosomal aberrations in IVLBCL, and an additional ring chromosome 11 could be a novel mechanism leading to the gainof 11q.
Journal ArticleDOI
Chromosome passenger complex is required for the survival of cells with ring chromosomes in fission yeast.
TL;DR: It is suggested that CPC is required for the survival of cells with circular chromosomes and sheds light on the possible roles of CPC in the maintenance of circular chromosomes.
Journal ArticleDOI
Ring chromosome with deletion 7q in acute myeloid leukaemia
TL;DR: An elderly patient with AML is reported who had deletion 7q (7q–) along with ring chromosome, which was demonstrated in conventional cytogenetics and fluoresecent in-situ hybridisation techniques.
References
More filters
Journal ArticleDOI
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.
Hartmut Döhner,Elihu H. Estey,Sergio Amadori,Frederick R. Appelbaum,Thomas Büchner,Alan Kenneth Burnett,Hervé Dombret,Pierre Fenaux,David Grimwade,Richard A. Larson,Francesco Lo-Coco,Tomoki Naoe,Dietger Niederwieser,Gert J. Ossenkoppele,Miguel A. Sanz,Jorge Sierra,Martin S. Tallman,Bob Löwenberg,Clara D. Bloomfield +18 more
TL;DR: An international expert panel is provided to provide updated evidence- and expert opinion-based recommendations for the diagnosis and management of AML, that contain both minimal requirements for general practice as well as standards for clinical trials.
Journal ArticleDOI
The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial
David Grimwade,Helen Walker,Fiona Oliver,Keith Wheatley,Christine J. Harrison,G Harrison,J. K. H. Rees,Ian Hann,Richard L. Stevens,Alan Kenneth Burnett,Anthony H. Goldstone +10 more
TL;DR: Subgroup analysis demonstrated that the three cytogenetically defined prognostic groups retained their predictive value in the context of secondary as well as de novo AML, within the pediatric age group and furthermore were found to be a key determinant of outcome from autologous or allogeneic bone marrow transplantation (BMT) in first CR.
Journal ArticleDOI
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)
John C. Byrd,Krzysztof Mrózek,Richard K. Dodge,Andrew J. Carroll,Colin G. Edwards,Diane C. Arthur,Mark J. Pettenati,Shivanand R. Patil,Kathleen W. Rao,Michael S. Watson,Prasad Koduru,Joseph O. Moore,Richard Stone,Robert J. Mayer,Eric J. Feldman,Frederick R. Davey,Charles A. Schiffer,Richard A. Larson,Clara D. Bloomfield +18 more
TL;DR: In this paper, the prognostic impact of cytogenetic abnormalities on complete remission (CR) rate, 5-year cumulative incidence of relapse (CIR), and 5-to-5-year overall survival (OS) of acute myeloid leukemia (AML) patients was investigated.
Journal ArticleDOI
Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study
Marilyn L. Slovak,Kenneth J. Kopecky,Peter A. Cassileth,David H. Harrington,Karl S. Theil,Anwar Mohamed,Elizabeth Paietta,Cheryl L. Willman,David R. Head,Jacob M. Rowe,Stephen J. Forman,Frederick R. Appelbaum +11 more
TL;DR: Cytogenetic risk status is a significant factor in predicting response of AML patients to therapy; however, to tighten treatment correlates within genetically defined AML subsets, a significantly larger leukemia cytogenetic database is warranted.
Journal ArticleDOI
Cytogenetic findings in 200 patients with multiple myeloma.
TL;DR: The most striking feature of patients with hyperdiploid karyotypes was the finding of consistent recurring trisomies for chromosomes 3, 5, 7, 9, 11, 15, 19, and 21, cosegregating together in many cases.